Home/ Stocks/ KPTI

Karyopharm Therapeutics Inc.

KPTI XNAS

$8.64 -0.34 (-3.84%) ▼ 15-min delayed

Open

$8.87

High

$9.00

Low

$8.54

Volume

295.5K

Market Cap

$194.84M

About Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).

Sector: PHARMACEUTICAL PREPARATIONS Employees: 228 Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2025	$146.07M	$-196,039,000	$-17.93
FY 2025	$146.07M	$-196,039,000	$-17.93
Q3 2025	$44.04M	$-33,127,000	$-3.82
Q2 2025	$37.93M	$-37,252,000	$-4.32

Related Market News

No specific coverage for KPTI yet. Check out our latest market news or earnings calendar.

Get KPTI Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Karyopharm Therapeutics Inc..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.